Oruka Therapeutics (ORKA) Net Income (QoQ) (2010 - 2024)
Oruka Therapeutics (ORKA) Net Income (QoQ) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,440.76 Bn | 66,440.47 Bn | - |
| 2 | Nanobiotix | 1,880.51 Bn | 1,880.45 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.94 Bn | 463.15 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.63 Bn | 115.38 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.30 Bn | 61.54 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.81 Bn | 62.81 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.59 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 954.50 Mn | 123.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -157.93% |
| Mar 31, 2024 | -528.61% |
| Dec 31, 2023 | 36.79% |
| Sep 30, 2023 | -15.67% |
| Jun 30, 2023 | -10.59% |
| Mar 31, 2023 | -17.46% |
| Dec 31, 2022 | 50.98% |
| Sep 30, 2022 | 34.46% |
| Jun 30, 2022 | -10.66% |
| Mar 31, 2022 | 41.83% |
| Dec 31, 2021 | -20.46% |
| Sep 30, 2021 | 2.52% |
| Jun 30, 2021 | -17.70% |
| Mar 31, 2021 | 21.68% |
| Dec 31, 2020 | -163.39% |
| Sep 30, 2020 | -52.92% |
| Jun 30, 2020 | 1.36% |
| Mar 31, 2020 | -7.67% |
| Dec 31, 2019 | -6.06% |
| Sep 30, 2019 | 19.50% |